Skip to main content
. 2016 Dec 8;9(2):269–284. doi: 10.1080/19420862.2016.1268305

Figure 6.

Figure 6.

Systemic and ocular PK profile of ABBV642 in preclinical animals. (A) Mean ( ± SD) serum concentrations of ABBV642 with H435A mutation (solid circle), a control DVD-Ig with H435A mutation (open square) and a control DVD-Ig with wild-type Fc (solid triangle) following a single 5 or 6.7 mg/kg intravenous dose in male B6.Cg-FcRn-276 mice. (B) Mean ( ± SEM) serum concentrations of ABBV642 after a 1 mg/kg intravenous dose in New Zealand White rabbits. (C) Mean ( ± SEM) serum concentrations of ABBV642 after a 0.59 mg ocular dose in New Zealand White rabbits. (D) Mean ( ± SEM) aqueous humor concentrations of ABBV642 after a 0.25 mg ocular dose in New Zealand White rabbits.